Third Pole
Third Pole, Inc., a Waltham-based manufacturer, develops transformative cardio-pulmonary medical devices.
Founded
2014Third Pole, Inc., a Waltham-based manufacturer, develops transformative cardio-pulmonary medical devices.
Third Pole, Inc., founded in Waltham, Massachusetts, is dedicated to developing transformative cardio-pulmonary medical devices. The company's core mission is to revolutionize patient care through innovative therapies and devices, with a vision to make advanced medical treatments more accessible. Third Pole specializes in investigational and inhaled nitric oxide devices aimed at improving cardio-pulmonary health. Their market focus is primarily within the United States, targeting healthcare providers and patients in need of advanced respiratory solutions.
Notable affiliated individuals include pioneers in medical device innovation and seasoned healthcare professionals. Third Pole has garnered significant attention from investors interested in cutting-edge medical technologies. Key achievements include the development of the first wearable drug-making platform, eNOfit, and the clearance of their portable inhaled nitric oxide device in early studies. The company's impact is marked by its commitment to enhancing patient care and its potential role in addressing respiratory challenges, including those posed by COVID-19.
Companies similar to Third Pole include Vero Biotech, Beyond Air, Polares and Pulmonx.
Third Pole was founded in 2014.
Third Pole's headquarters is located in Waltham, MA, US.
Third Pole's most recent funding round was for $32M (USD) in December 2022.
As of Dec 14, 2022, Third Pole has disclosed funding of $85.8M (USD). Undisclosed round amounts are excluded.
Third Pole has 38 employees as of Feb 5, 2024.
Pulmonx
pulmonx.com
